1. Hedayat M, Massaad MJ, Lee YN, Conley ME, Orange JS, Ohsumi TK, Al-Herz W, Notarangelo LD, Geha RS, Chou J. Lessons in gene hunting: A RAG1 mutation presenting with agammaglobulinemia and absence of B cells. J Allergy Clin Immunol. 2014 Jun 27.
  2. Meazza R, Tuberosa C, Cetica V, Falco M, Parolini S, Grieve S, Griffiths GM, Sieni E, Marcenaro S, Micalizzi C, Montin D, Fagioli F, Moretta A, Mingari MC, Moretta L, Notarangelo LD, Bottino C, Aricò M, Pende D. Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis. J Allergy Clin Immunol. 2014 Jun 27.
  3. Bouma G, Carter NA, Recher M, Malinova D, Adriani M, Notarangelo LD, Burns SO, Mauri C, Thrasher AJ. Exacerbated experimental arthritis in Wiskott-Aldrich syndrome protein deficiency: Modulatory role of regulatory B cells. Eur J Immunol. 2014 Jun 19.
  4. Felgentreff K, Du L, Weinacht KG, Dobbs K, Bartish M, Giliani S, Schlaeger T, DeVine A, Schambach A, Woodbine LJ, Davies G, Baxi SN, van der Burg M, Bleesing J, Gennery A, Manis J, Pan-Hammarström Q, Notarangelo LD. Differential role of nonhomologous end joining factors in the generation, DNA damage response, and myeloid differentiation of human induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8889-94.

  1. Haddad E, Allakhverdi Z, Griffith LM, Cowan MJ, Notarangelo LD.Survey on retransplantation criteria for patients with severe combined immunodeficiency.J Allergy Clin Immunol. 2014 Feb;133(2):597-9. doi: 10.1016/j.jaci.2013.10.022.
  2. Schulz EG, Meisig J, Nakamura T, Okamoto I, Sieber A, Picard C, Borensztein M, Saitou M, Blüthgen N, Heard E. The two active X chromosomes in female ESCs block exit from the pluripotent state by modulating the ESC signaling network. Cell Stem Cell. 2014 Feb 6;14(2):203-16. doi: 10.1016/j.stem.2013.11.022.
  3. Magalon J, Gamerre M, Picard C, Chabannon C.Increase the quality of banked cord blood units without limiting HLA diversity: how cord blood banks could face this dilemma. Transfusion. 2014 Feb;54(2):495-6. doi: 10.1111/trf.12439.

  1. Seidel MG, Duerr C, Woutsas S, Schwerin-Nagel A, Sadeghi K, Neesen J, Uhrig S, Santos-Valente E, Pickl WF, Schwinger W, Urban C, Boztug K, Förster-Waldl E. A novel immunodeficiency syndrome associated with partial trisomy 19p13. J Med Genet. 2014 Jan 15. doi: 10.1136/jmedgenet-2013-102122.

  2. Yu X, Almeida J, Darko S, van der Burg M, Deravin SS, Malech H, Gennery A, Chinn I, Markert ML, Douek DC, Milner JD. Human syndromes of immunodeficiency and dysregulation are characterized by distinct defects in T-cell receptor repertoire development. J Allergy Clin Immunol. 2014 Jan 7. pii: S0091-6749(13)01782-X. doi: 10.1016/j.jaci.2013.11.018.

  3. Habel A, Herriot R, Kumararatne D, Allgrove J, Baker K, Baxendale H, Bu'lock F, Firth H, Gennery A, Holland A, Illingworth C, Mercer N, Pannebakker M, Parry A, Roberts A, Tsai-Goodman B. Towards a safety net for management of 22q11.2 deletion syndrome: guidelines for our times. Eur J Pediatr. 2014 Jan 3.

Page 3 of 3


Site Last Modified

  • Last Modified: Friday 10 February 2023, 01:23:37.

Visitors Counter

This WeekThis Week99
This MonthThis Month1305
All DaysAll Days823822


This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Casablanca September A-Project








Go to top